Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy.
Voûte
P A
PA
Academic Medical Centre, Dpt. of Pediatric Oncology, the Netherlands Cancer Institute, Amsterdam.
Hoefnagel
C A
CA
de Kraker
J
J
Valdes Olmos
R
R
Bakker
D J
DJ
van de Kleij
A J
AJ
D019797:3-Iodobenzylguanidine; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D007462:Iodobenzenes / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009447:Neuroblastoma / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000532:radiotherapy*; D011877:Radionuclide Imaging
D000970:Antineoplastic Agents; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D019797:3-Iodobenzylguanidine